Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 151–178 of 178 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07126665	A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors	recruiting	Phase 1 / Phase 2	116	Minghui Pharmaceutical (Hangzhou) LtdINDUSTRY	1	Nov 18, 2025	clinicaltrials
NCT07196579	Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors	not yet recruiting	Phase 1	30	TCRx Therapeutics Co.LtdINDUSTRY	1	Sep 29, 2025	clinicaltrials